» Articles » PMID: 15021933

[Photodynamic Therapy of Cutaneous Leishmaniasis. A Promising New Therapeutic Modality]

Overview
Journal Hautarzt
Specialty Dermatology
Date 2004 Mar 17
PMID 15021933
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We report about a 19-year-old Turkish patient who presented with cutaneous leishmaniasis after a holiday in Turkey. Cutaneous leishmaniasis often heals spontaneously leading to life-long immunity, but it can persist and lead to extensive scarring. In the literature, many therapeutic modalities have been reported; however, they can be accompanied by severe side effects. In our patient, photodynamic therapy resulted in healing of the lesion with only slight hypopigmentation.

Citing Articles

Monitoring the efficacy of antimicrobial photodynamic therapy in a murine model of cutaneous leishmaniasis using L. major expressing GFP.

Latorre-Esteves E, Akilov O, Rai P, Beverley S, Hasan T J Biophotonics. 2010; 3(5-6):328-35.

PMID: 20376860 PMC: 2876225. DOI: 10.1002/jbio.201000008.


[The leishmaniasis - a parasitel infection as differential diagnosis of malignant tumours of oral mucosa. A case report and review of literature].

Wysluch A, Sommerer F, Ramadan H, Loeffelbein D, Wolff K, Holzle F Mund Kiefer Gesichtschir. 2007; 11(3):167-73.

PMID: 17566798 DOI: 10.1007/s10006-007-0061-9.

References
1.
Navin T, Arana B, Arana F, Berman J, Chajon J . Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala. J Infect Dis. 1992; 165(3):528-34. DOI: 10.1093/infdis/165.3.528. View

2.
Gardlo K, Horska Z, Enk C, Rauch L, Megahed M, Ruzicka T . Treatment of cutaneous leishmaniasis by photodynamic therapy. J Am Acad Dermatol. 2003; 48(6):893-6. DOI: 10.1067/mjd.2003.218. View

3.
Herwaldt B . Leishmaniasis. Lancet. 1999; 354(9185):1191-9. DOI: 10.1016/S0140-6736(98)10178-2. View

4.
Bahamdan K, Tallab T, Johargi H, Nourad M, Ibrahim K, el Sherbini A . Terbinafine in the treatment of cutaneous leishmaniasis: a pilot study. Int J Dermatol. 1997; 36(1):59-60. DOI: 10.1046/j.1365-4362.1997.00021.x. View

5.
Saldanha A, Romero G, Merchan-Hamann E, Magalhaes A, Macedo V . [A comparative study between sodium stibogluconate BP 88R and meglumine antimoniate in the treatment of cutaneous leishmaniasis. I. The efficacy and safety]. Rev Soc Bras Med Trop. 1999; 32(4):383-7. DOI: 10.1590/s0037-86821999000400008. View